Efficacy, Safety, and Pharmacokinetics of Shu Yang IVIG

Conditions: Primary Immunodeficiency Disease Interventions: Biological: IVIG Sponsors: Azidus Brasil; Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials